Prodrugs of fumarates and their use in treating various diseases
US-10596140-B2 · Mar 24, 2020 · US
Prodrugs of fumarates and their use in treating various diseases
US11679092B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11679092-B2 |
| Application number | US-202117365199-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 1, 2021 |
| Priority date | Mar 14, 2013 |
| Publication date | Jun 20, 2023 |
| Grant date | Jun 20, 2023 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
First claim
Opening claim text (preview).
What is claimed: 1. A compound having the formula or a pharmaceutically acceptable salt thereof. 2. A pharmaceutical composition comprising the compound of claim 1 , or a pharmaceutically acceptable salt thereof. 3. A method of treating multiple sclerosis in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of the compound of claim 1 . 4. A method of treating multiple sclerosis in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of the composition of claim 2 .
Assignees
Inventors
Classifications
- A61K31/225Primary
Polycarboxylic acids · CPC title
having the nitrogen atom of at least one of the carboxamide groups further acylated · CPC title
with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton · CPC title
having no double bonds between ring members or between ring members and non-ring members · CPC title
with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11679092B2 cover?
- The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
- Who is the assignee on this patent?
- Alkermes Pharma Ireland Ltd
- What technology area does this patent fall under?
- Primary CPC classification A61K31/225. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).